본문 바로가기 주메뉴 바로가기
국회도서관 홈으로 정보검색 소장정보 검색

결과 내 검색

동의어 포함

초록보기

The cytotoxicity of Jaspine B was evaluated across a concentration range of 0.5–50 μM, yielding a half maximal inhibitory concentration (IC50) of 2.6 μM for HepG2 human hepatocellular carcinoma cells. To explore the mechanisms of Jaspine B, we investigated the expression of sphingosine kinase 1 (SphK1), a rate-limiting enzyme involved in the production of sphingosine-1-phosphate (S1P) from sphingosine, and the modulation of sphingolipids in HepG2 cells. Jaspine B reduced SphK1 expression and S1P levels in a dose-dependent manner. Additionally, flow cytometry analysis indicated that Jaspine B induces apoptosis in HepG2. In HepG2-xenografted mice, Jaspine B treatment (20 mg/kg/every other day for four weeks) reduced tumor size without significant changes in either body or organ weight. The anti-cancer effect in these mice was linked to reduced SphK1 expression in tumor tissue and lower plasma S1P levels. The concentration of Jaspine B in tumor tissue was 4.64 ± 2.05 μM, which exceeded its IC50 value (2.6 μM for cytotoxicity and 1.4 μM for SphK1 inhibition), further supporting its efficacy through SphK1inhibition. The anti-cancer effect and reduced plasma S1P levels induced by Jaspine B were comparable to PF543, a selective SphK1 inhibitor, in HepG2-xenografted mice. In conclusion, this study provides in vitro and in vivo evidence that Jaspine B is a promising anti-cancer agent for hepatocellular carcinoma, acting through SphK1 inhibition, with favorable pharmacokinetic and tumor distribution properties. This study also suggested that reduced plasma S1P levels may serve as a therapeutic biomarker for SphK1 inhibitors in hepatocellular carcinoma treatment.

권호기사

권호기사 목록 테이블로 기사명, 저자명, 페이지, 원문, 기사목차 순으로 되어있습니다.
기사명 저자명 페이지 원문 목차
Targeting NF-κB in diabetic nephropathy : exploring the therapeutic potential of phytoconstituents Beena Levakumar Abhirami, Anithakumari Aswathy Krishna, Alaganandam Kumaran, Chun-Hui Chiu p. 577-637
Insights into biological activities profile of gingerols and shogaols for potential pharmacological applications Anis Najwa Abdul Rani, Anand Gaurav, Vannajan Sanghiran Lee, Nadiah Mad Nasir, Sharifuddin Md Zain, Vaishali M. Patil, Ming Tatt Lee p. 638-675
NRF2 activation in cancer and overview of NRF2 small molecule inhibitors Hoang Hai Ngo, Bo-Yeong Yu, Jeong-Eun Lee, Hyunwoo Kim, Young-Sam Keum p. 676-705
Enhancer regulation in cancer : from epigenetics to m6A RNA modification Arathy Vasukutty, Poshan Yugal Bhattarai, Hong Seok Choi p. 706-735
9H-carbazole derivatives from a Streptomyces species under potassium iodide stress and their anti-inflammatory properties Pengcheng Yan, Yunlong Liu, Jibin Liu, Linmeng Chen, Ning Li, Weiming Zhu p. 736-744
(A) novel multi-target compound mitigates amyloid plaques, synaptic deficits, and neuroinflammation in Alzheimer’s disease models Yeongyeong Lee, Sukmin Han, Jeongmi Lee, Yongeun Cho, Jun-Sik Kim, Yeji Jeon, Heewon Cho, Heejin Yoo, Yujung Byun, Tai Kyoung Kim ... [et al.] p. 745-764
Curcumin monoglucuronide protects cartilage from progressive degeneration by blocking MMP-13 Himadri Shekhar Roy, Chirag Kulkarni, K.M. Neethu, Anand Babu, Malika Arora, Govindasamy Jayamurugan, Dipankar Mandal, Rajdeep Guha, Naibedya Chattopadhyay, Deepa Ghosh p. 765-781
Silybin inhibits succinate production and secretion in hepatocytes to reverse liver fibrosis Xule Yang, Yunge Lou, Huan Li, Yuanyuan Ma, Zihan Wang, Jiye Aa, Guangji Wang, Yuan Xie p. 782-797
Sphingolipid modulation and anti-tumor activity of Jaspine B in HepG2 bearing mice Jihoon Lee, Ji-Hyeon Jeon, Minyeong Pang, Min-Koo Choi, Dongjoo Lee, Im-Sook Song p. 798-813
Neuroprotective effects of taurine in a rodent model of Parkinson’s disease involve modulating astrocyte-mediated inflammation Sung Min Moon, Jaehoon Kim, Jaeheon Seol, Seonguk Yang, Duwon Jung, Chang Yup Kim, Chang Seok Kim, Ki Wung Chung, Young-Suk Jung, Seung-Cheol Chang, Hae Young Chung, Jaewon Lee p. 814-829